Share Twitter LinkedIn Facebook Email Robert Z. Orlowski, MD from MD Anderson Cancer Center discusses if MRD negative patients can stop maintenance and continue treatment until the time of progression at the 2017 American Society of Hematology.
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read